BidaskClub cut shares of Sientra (NASDAQ:SIEN) from a hold rating to a sell rating in a report published on Tuesday morning.
Several other equities research analysts have also recently commented on the stock. Canaccord Genuity reaffirmed a buy rating and issued a $14.00 price objective on shares of Sientra in a research report on Sunday, October 8th. Zacks Investment Research raised shares of Sientra from a sell rating to a hold rating in a research report on Tuesday, January 2nd. ValuEngine raised shares of Sientra from a sell rating to a hold rating in a research report on Sunday, December 31st. Stifel Nicolaus reaffirmed a hold rating and issued a $14.00 price objective (up from $11.00) on shares of Sientra in a research report on Wednesday, September 27th. Finally, William Blair raised shares of Sientra from a market perform rating to an outperform rating in a research report on Wednesday, September 13th. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company. The stock has a consensus rating of Hold and a consensus target price of $15.00.
Shares of Sientra (NASDAQ:SIEN) traded down $0.63 during midday trading on Tuesday, hitting $12.52. 219,900 shares of the stock were exchanged, compared to its average volume of 169,288. The company has a market capitalization of $242.83, a PE ratio of -4.39 and a beta of -1.47. Sientra has a 52 week low of $7.20 and a 52 week high of $16.68. The company has a current ratio of 2.87, a quick ratio of 1.92 and a debt-to-equity ratio of 0.57.
A number of institutional investors and hedge funds have recently bought and sold shares of SIEN. Bamco Inc. NY lifted its position in Sientra by 109.3% in the 2nd quarter. Bamco Inc. NY now owns 471,500 shares of the medical instruments supplier’s stock valued at $4,583,000 after acquiring an additional 246,183 shares in the last quarter. EAM Investors LLC bought a new stake in Sientra in the 3rd quarter valued at $3,018,000. Pura Vida Investments LLC bought a new stake in Sientra in the 3rd quarter valued at $2,892,000. State Street Corp bought a new stake in Sientra in the 2nd quarter valued at $1,449,000. Finally, Northern Trust Corp lifted its position in Sientra by 449.4% in the 2nd quarter. Northern Trust Corp now owns 149,227 shares of the medical instruments supplier’s stock valued at $1,451,000 after acquiring an additional 122,066 shares in the last quarter. 76.63% of the stock is currently owned by institutional investors and hedge funds.
Sientra Company Profile
Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.